207 related articles for article (PubMed ID: 35057907)
1. Association of Lipoprotein(a) With Atherosclerotic Plaque Progression.
Kaiser Y; Daghem M; Tzolos E; Meah MN; Doris MK; Moss AJ; Kwiecinski J; Kroon J; Nurmohamed NS; van der Harst P; Adamson PD; Williams MC; Dey D; Newby DE; Stroes ESG; Zheng KH; Dweck MR
J Am Coll Cardiol; 2022 Jan; 79(3):223-233. PubMed ID: 35057907
[TBL] [Abstract][Full Text] [Related]
2. Association of Lipoprotein(a) Levels With Myocardial Infarction in Patients With Low-Attenuation Plaque.
Yu MM; Wang ML; Wang JJ; Lin BL; Zhao X; Tao XW; Chen YY; Li PY; Zhang JK; Ge JB; Jin H; Zeng MS
J Am Coll Cardiol; 2024 May; 83(18):1743-1755. PubMed ID: 38692827
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein(a) is an important factor to determine coronary artery plaque morphology in patients with acute myocardial infarction.
Hikita H; Shigeta T; Kojima K; Oosaka Y; Hishikari K; Kawaguchi N; Nakashima E; Sugiyama T; Akiyama D; Kamiishi T; Kimura S; Takahashi Y; Kuwahara T; Sato A; Takahashi A; Isobe M
Coron Artery Dis; 2013 Aug; 24(5):381-5. PubMed ID: 23652366
[TBL] [Abstract][Full Text] [Related]
4. Association of Lipoprotein (a) With Coronary-Computed Tomography Angiography-Assessed High-Risk Coronary Disease Attributes and Cardiovascular Outcomes.
Dai N; Chen Z; Zhou F; Zhou Y; Hu N; Duan S; Wang W; Yu Y; Zhang L; Qian J; Ge J
Circ Cardiovasc Imaging; 2022 Dec; 15(12):e014611. PubMed ID: 36503252
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.
Puri R; Ballantyne CM; Hoogeveen RC; Shao M; Barter P; Libby P; Chapman MJ; Erbel R; Arsenault BJ; Raichlen JS; Nissen SE; Nicholls SJ
Atherosclerosis; 2017 Aug; 263():137-144. PubMed ID: 28641153
[TBL] [Abstract][Full Text] [Related]
6. Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART).
Williams MC; Kwiecinski J; Doris M; McElhinney P; D'Souza MS; Cadet S; Adamson PD; Moss AJ; Alam S; Hunter A; Shah ASV; Mills NL; Pawade T; Wang C; Weir McCall J; Bonnici-Mallia M; Murrills C; Roditi G; van Beek EJR; Shaw LJ; Nicol ED; Berman DS; Slomka PJ; Newby DE; Dweck MR; Dey D
Circulation; 2020 May; 141(18):1452-1462. PubMed ID: 32174130
[TBL] [Abstract][Full Text] [Related]
7. Lipoprotein(a) and apolipoprotein(a) isoform size: Associations with angiographic extent and severity of coronary artery disease, and carotid artery plaque.
Ooi EM; Ellis KL; Barrett PHR; Watts GF; Hung J; Beilby JP; Thompson PL; Stobie P; McQuillan BM
Atherosclerosis; 2018 Aug; 275():232-238. PubMed ID: 29960898
[TBL] [Abstract][Full Text] [Related]
8. High-density lipoprotein cholesterol, triglycerides, and characteristics of coronary atherosclerosis in patients with significant coronary artery disease newly diagnosed by computed tomography coronary angiography.
Oleksiak A; Kępka C; Rucińska K; Marcinkiewicz K; Demkow M; Kruk M
Kardiol Pol; 2023; 81(3):273-280. PubMed ID: 36475513
[TBL] [Abstract][Full Text] [Related]
9. Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease.
Niccoli G; Cin D; Scalone G; Panebianco M; Abbolito S; Cosentino N; Jacoangeli F; Refaat H; Gallo G; Salerno G; Volpe M; Crea F; De Biase L
Atherosclerosis; 2016 Mar; 246():214-20. PubMed ID: 26803430
[TBL] [Abstract][Full Text] [Related]
10. Impact of serum lipoprotein (a) level on coronary plaque progression and cardiovascular events in statin-treated patients with acute coronary syndrome: a yokohama-acs substudy.
Matsushita K; Hibi K; Komura N; Kimura Y; Matsuzawa Y; Konishi M; Maejima N; Iwahashi N; Kosuge M; Ebina T; Tamura K; Kimura K
J Cardiol; 2020 Jul; 76(1):66-72. PubMed ID: 32037254
[TBL] [Abstract][Full Text] [Related]
11. Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity.
Pokrovsky SN; Afanasieva OI; Safarova MS; Balakhonova TV; Matchin YG; Adamova IYU; Konovalov GA; Ezhov MV
Atheroscler Suppl; 2017 Nov; 30():166-173. PubMed ID: 29096833
[TBL] [Abstract][Full Text] [Related]
12. Coronary plaque volume and predictors for fast plaque progression assessed by serial coronary CT angiography-A single-center observational study.
Weber C; Deseive S; Brim G; Stocker TJ; Broersen A; Kitslaar P; Martinoff S; Massberg S; Hadamitzky M; Hausleiter J
Eur J Radiol; 2020 Feb; 123():108805. PubMed ID: 31896023
[TBL] [Abstract][Full Text] [Related]
13. Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries.
Hartmann M; von Birgelen C; Mintz GS; Stoel MG; Eggebrecht H; Wieneke H; Fahy M; Neumann T; van der Palen J; Louwerenburg HW; Verhorst PM; Erbel R
J Am Coll Cardiol; 2006 Aug; 48(3):446-52. PubMed ID: 16875967
[TBL] [Abstract][Full Text] [Related]
14. Relationship between changes in pericoronary adipose tissue attenuation and coronary plaque burden quantified from coronary computed tomography angiography.
Goeller M; Tamarappoo BK; Kwan AC; Cadet S; Commandeur F; Razipour A; Slomka PJ; Gransar H; Chen X; Otaki Y; Friedman JD; Cao JJ; Albrecht MH; Bittner DO; Marwan M; Achenbach S; Berman DS; Dey D
Eur Heart J Cardiovasc Imaging; 2019 Jun; 20(6):636-643. PubMed ID: 30789223
[TBL] [Abstract][Full Text] [Related]
15. Evolocumab attenuate pericoronary adipose tissue density via reduction of lipoprotein(a) in type 2 diabetes mellitus: a serial follow-up CCTA study.
Yu MM; Zhao X; Chen YY; Tao XW; Ge JB; Jin H; Zeng MS
Cardiovasc Diabetol; 2023 May; 22(1):121. PubMed ID: 37217967
[TBL] [Abstract][Full Text] [Related]
16. High-density lipoprotein cholesterol and the risk of obstructive coronary artery disease beyond low-density lipoprotein cholesterol in non-diabetic individuals.
Kim YG; Cho YR; Park GM; Won KB; Ann SH; Yang DH; Kang JW; Lim TH; Kim HK; Choe J; Lee SW; Kim YH; Yang YJ; Kim SJ; Lee SG
Eur J Prev Cardiol; 2020 May; 27(7):706-714. PubMed ID: 31023096
[TBL] [Abstract][Full Text] [Related]
17. Association of Cardiovascular Disease Risk Factor Burden With Progression of Coronary Atherosclerosis Assessed by Serial Coronary Computed Tomographic Angiography.
Han D; Berman DS; Miller RJH; Andreini D; Budoff MJ; Cademartiri F; Chinnaiyan K; Choi JH; Conte E; Marques H; de Araújo Gonçalves P; Gottlieb I; Hadamitzky M; Leipsic J; Maffei E; Pontone G; Shin S; Kim YJ; Lee BK; Chun EJ; Sung JM; Lee SE; Virmani R; Samady H; Stone P; Narula J; Bax JJ; Shaw LJ; Lin FY; Min JK; Chang HJ
JAMA Netw Open; 2020 Jul; 3(7):e2011444. PubMed ID: 32706382
[TBL] [Abstract][Full Text] [Related]
18. Association of lipoprotein(a) level with short- and long-term outcomes after CABG: The role of lipoprotein apheresis.
Ezhov MV; Afanasieva OI; Il'ina LN; Safarova MS; Adamova IY; Matchin YG; Konovalov GA; Akchurin RS; Pokrovsky SN
Atheroscler Suppl; 2017 Nov; 30():187-192. PubMed ID: 29096836
[TBL] [Abstract][Full Text] [Related]
19. Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging Substudy-Brief Report.
Hippe DS; Phan BAP; Sun J; Isquith DA; O'Brien KD; Crouse JR; Anderson T; Huston J; Marcovina SM; Hatsukami TS; Yuan C; Zhao XQ
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):673-678. PubMed ID: 29301785
[TBL] [Abstract][Full Text] [Related]
20. Coronary computed tomography angiography evaluation of plaque morphology and its relationship to HDL and total cholesterol to HDL ratio.
Manubolu VS; Verghese D; Lakshmanan S; Alalawi L; Kinninger A; Bitar JA; Calicchio F; Ahmad K; Ghanem A; Javier DA; Mangaoang C; Flores F; Dailing C; Roy SK; Budoff MJ
J Clin Lipidol; 2022; 16(5):715-724. PubMed ID: 35778256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
